← Research LibraryThe BriefFY2024 10-K · headline figures audited against SEC data
Revenue decreased 1.8% to $2.2M, while Net income increased 49.3% to ($1.7M).
The read at a glance✓ Audited against SEC data
- Scale — FY2024 revenue $2.2MWatch
- Profitability — Net income ($1.7M)Watch
- Cash generation — Free cash flow N/ANote
- Accounting — Formula distress score · no manipulation flag · earnings quality greyWatch
- Insiders — 0 buys; 0 sells in 365 daysNote
- Capital — Comparable payout data unavailableNote
Business
US NUCLEAR CORP.: 2 Following the merger, we began to provide a full line of radiation detection equipment and services to clients' industries that range from nuclear reactor plants, universities, local and state hospitals, government agencies, and emergency medical technicians or EMT/first responders.
Where the revenue comes from
Fiscal 2025, as US NUCLEAR CORP. reports it. History and quarterly detail are in the app.
Leadership changes
From US NUCLEAR CORP.'s own filings, the day they're filed.
- Michael Pope · member · departureeff. 2026-04-16
- Michael Pope · director · appointmenteff. 2023-10-06
- Michael Pope · director · appointmenteff. 2023-10-06
Latest filings
- 10-K · Annual report2026-06-23
- 8-K · Company announcement2026-04-22
- 10-Q · Quarterly report2026-01-27
- 8-K · Company announcement2025-11-04
- 10-Q · Quarterly report2025-10-27
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about US NUCLEAR CORP., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.